Annual report pursuant to Section 13 and 15(d)

Basic and Diluted Net Loss Per Share - Schedule of Shares of Common Stock Equivalents Were Excluded from Computation of Diluted Net Loss Per Share (Details)

v3.21.1
Basic and Diluted Net Loss Per Share - Schedule of Shares of Common Stock Equivalents Were Excluded from Computation of Diluted Net Loss Per Share (Details) - shares
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Total common stock equivalents 1,585,687 824,354
Common Stock Warrants [Member]    
Total common stock equivalents 780,935 516,748
Common Stock Convertible Notes [Member]    
Total common stock equivalents 638,247 105,360
Common Stock Options [Member]    
Total common stock equivalents 166,505 202,246